Introduction
Superparamagnetic iron oxide nanoparticles (SPIONs) are a very useful class of magnetic resonance imaging (MRI) contrast agents 1 that can be targeted to specific biological sites by recognition ligands attached to their surface. Such SPIONs loaded with therapeutic molecules, such as drugs, 2 microRNAs, 3 or shRNA, 4 are useful both as diagnostic and therapeutic agents, and an important, open question is how to accurately determine their concentrations in the target tissues in vivo, in a non-invasive manner. The direct methods that have been applied to SPION quantitation include both nonmagnetic schemes, such as positron emission tomography-computed tomography 5, 6 and those utilizing the magnetic properties of the SPIONs, which include SQUID studies. [7] [8] [9] An attractive alternative to direct detection of the particles is to indirectly measure their concentration by examining their influence on the magnetic resonance relaxation characteristics of tissue water 10 or on the MRI-determined phase of the water signal, as in quantitative susceptibility mapping (QSM). 11 These indirect techniques offer the promise of high sensitivity due to the large number of water protons present in biological tissues (∼10 22 /g), although it is still not clear whether QSM is sensitive enough to measure SPION iron concentrations less than millimolar. Relaxometry, which is based on the large increase in proton transverse relaxation rates, particularly for R 2 *, that occur as water molecules diffuse through the susceptibility gradients surrounding magnetic nanoparticles, has been shown to be able to detect iron concentrations, in vitro, in the parts per billion range. 12 Therefore, many authors have attempted to use simple R 2 , or R 2 * measurements to determine nanoparticle iron concentrations. [13] [14] [15] [16] [17] [18] [19] However, R 2 * is determined by a number of tissue features independent of added SPIONs, predominant among these are susceptibility artifacts arising from tissue/air interfaces which increase R 2 * and lead to an overestimation of the SPION concentration. 13 Furthermore, the MRI signal loss associated with large increases in R 2 * results in hypointense regions in tissue that are often difficult to distinguish from localized SPIONs. This has led to a number of complicated schemes to produce MR images with positive, rather than negative contrast [20] [21] [22] [23] [24] many of which require extensive scanner reprogramming and would appear rather difficult to translate into the clinic.
We have, therefore, developed a simple, general, multiparametric, quantitative MRI method, which we call [Fe]MRI (pronounced fem-ree) for the imaging of the concentration of added nanoparticle iron ([Fe] ), and other magnetic objects, in cells and tissues that produces MR images with positive contrast and avoids many of these earlier issues and can be easily applied to cells, tissues, organs, animals, and patients.
[Fe]MRI utilizes the enhancements produced by SPIONs on both the longitudinal and transverse relaxation rates, R 1 and R 2 , but not R 2 *, and is based on the contrast difference between T 1 -weighted (T 1 w) and T 2 -weighted (T 2 w) MR images rather than their intensities. Application of [Fe] MRI theory enabled us to correctly interpret the qualitative contrast in T 1 w and T 2 w MR images of SPIONs and SPION-labeled prostate tumor cells in agarose gels. We then quantitatively validated the method through the measurement of iron for SPIONs in the same samples.
The biological specificity of a SPION is determined by the recognition ligand attached to the surface of a nanoparticle. Our previous work 25, 26 had suggested that prostate specific membrane antigen (PSMA) would serve as a good target epitope for prostate cancer cells. PSMA is a cell-surface protein that is vastly overexpressed on prostate tumors. [27] [28] [29] SPIONs were constructed with an attached antibody against PSMA. Several human prostate tumor cell lines, including LNCaP, C4-2, 30 and DU145 cells, were cultured and the expression of PSMA was measured by flow cytometry. We found that LNCaP and C4-2 cells expressed large numbers of PSMA molecules, while DU145 cells were virtually devoid of expression. We applied [Fe] MRI to an analysis of the specific binding of anti-PSMA-conjugated SPIONs to PSMA-positive LNCaP and PSMA-negative DU145 cells in vitro in agarose gels and found that [Fe]MRI measurements quantitatively discriminated among prostate tumor cell types based on their PSMA expression level. These results supported the subsequent use of [Fe] MRI for the specific monitoring of [Fe] in tumors in vivo in mice, which we will report separately.
Theory of [Fe]MRI
Of fundamental significance for the quantitation of [Fe] by means of MRI, is the image contrast, C, defined as
where S A is the intensity of the voxel of interest and S B is the intensity of a reference voxel. Note that if S A = S B then C =0, and if S A =0, then C =−1, and the contrast of a voxel formally varies from C =−1 to C =+∞. MRI contrast agents alter S A while, presumably leaving S B unaffected. The intensity of the nuclear magnetic resonance (NMR) signal from a voxel is a function of its intrinsic relaxation characteristics (T 1 , T 2 ) modified both by the presence of extrinsic agents and by the acquisition parameters (T R , T E ), where T 1 and T 2 are the longitudinal and transverse relaxation times, and T R , and T E are the recycle and echo times, respectively. MRI contrast agents alter the T 1 and T 2 relaxation times of the abundant water NMR signal in tissues. Therefore, the relaxivity, r, of a contrast agent is determined by its perturbation of the water proton relaxation times. This relaxation rate enhancement of a contrast agent is a linear function of its concentration, and has different values for the water T 1 or T 2 because each of these tissue relaxation characteristics arises from different physical correlation times. Therefore, the unperturbed water longitudinal and transverse relaxation rates, R 1 (=1/T 1 ) and R 2 (=1/T 2 ) are modified in the presence of a contrast agent by
where c is the concentration of the contrast agent and r 1 and r 2 are its longitudinal and transverse relaxivities, which are easily measured ( Figure 1 ) for both free SPIONs and for SPIONs attached to or internalized by cells. In the absence of contrast agents, c =0, and the NMR signal, S, in a voxel is a function of the intrinsic relaxation times and the acquisition parameters:
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where M is an overall, machine-dependent amplitude factor proportional to the number of nuclei in the voxel. We refer to this as the tissue background signal. Note that based on Equation 4 the NMR signal in a voxel can be obtained in two rather different ways: one in which T E ∼ T 2 and T R .. T 1 , which is called T 2 w where contrast is primarily determined by differences in the tissue transverse relaxation times from voxel to voxel, and another in which T E ,, T 2 and T R ∼ T 1 , which is called T 1 w where voxel to voxel contrast is primarily determined by differences in their longitudinal relaxation times.
In the presence of a contrast agent, Equation 4 needs to be modified by inserting Equations 2 and 3 into the exponentials so that the voxel signal additionally depends on the concentration, c, of the contrast agent.
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Now, since Equation 4 shows that the NMR signal is a function of both the recycle and the echo times used to acquire the data, and that the relaxivities of the contrast agent enter separately in the exponentials for the echo and recovery amplitudes, one can imagine that contrast agents with differences in r 1 and r 2 will have separate effects on the signal amplitude depending on the set of acquisition parameters. Note here that SPIONs have r 2 .. r 1 , and hence are more potent in influencing tissue water T 2 than T 1 on a molar basis.
By using Equation 4 for the reference (or, from now on, we refer to this as a tissue background) voxel signal, and Equation 5 for the NMR signal from the voxel in the presence of the contrast agent, we can define the contrast, C(c), in a voxel, with respect to the tissue background as 
The tissue contrast depends on Equation 6 , in a complex manner, on the concentration of the contrast agent. At first glance, it would seem that Equation 6 is too complex to be useful, but, on closer inspection, it provides the key to quantitation of the contrast agent because we can write a separate version of Equation 6 for each of the two important types of nuclear resonance images; one for the T 1 w case and another for the T 2 w case. Furthermore, to simplify the analysis, the tissue background signal, while computed in the theory, is simply measured from the voxels of interest in an MR image in the absence of contrast agent, and is therefore just a number. Then, we have two equations for voxel contrast, one for the T 1 w case and another for the T 2 w case. Let us denote them by subscripts 1 and 2, respectively. 
These can then be rewritten in an obvious notation as (12) and to determine the unknown function, g. We found that a typical set of MRI parameters gave ( Figure 2 Prior to embarking on an experimental examination of this theory, it was useful to estimate the expected additional iron concentration in cells and tissues from injected SPIONs. A simple model for an LNCaP prostate tumor cell is a sphere with a diameter ∼18 µm. Assuming that SPIONs can completely cover the surface, we find that ∼325 1.05 µm Dynabeads, and 9×10 5 
Materials and methods Materials
Fluorescein-conjugated streptavidin was obtained from Thermo Fisher Scientific (Waltham, MA, USA). Dynabeads ® MyOne™ Streptavidin were obtained from Dynal Biotech, and MACS ® Streptavidin MicroBeads (µMACS) were obtained from Miltenyi Biotec. Anti-PSMA antibody (clone 3C6) was purchased from Northwest Biotherapeutics (Bothell, WA, USA). Antibody was biotinylated using EZLink™ Sulfo-NHS-LC-Biotin from Pierce (Rockford, IL, USA). Fully humanized anti-PSMA antibody J591 was purchased from N Bander (Weill Cornell Medical College, New York, NY, USA). The prostate cancer cell lines LNCaP, PC-3, and DU-145 were purchased from the American Tissue Type Collection (Manassas, VA, USA). The C4-2 prostate cancer cell line was a kind gift from Dr GN Thalmann (University of Bern, Bern, Switzerland). 30 
Iron assays
SPIONs, gels containing SPIONs, and SPION-labeled cell suspensions were dissolved in 0.5 mL of 6 N HCl (SigmaAldrich, St Louis, MO, USA) at 95°C overnight in sealed tubes. Aliquots (0.1 mL) of the resulting solution were assayed for iron using the Prussian blue reaction by adding them to 0.9 mL of 10% K 4 Fe(CN) 6 (Sigma-Aldrich), incubating at 60°C for 30 minutes, and reading the absorbance at 690 nm. Standard curves (n=7) prepared using 1.00 mM FeCl 3 (Sigma-Aldrich) gave an extinction coefficient of 9,165±148 L/mol cm.
cell culture
LNCaP cells were cultured in Roswell Park Memorial Institute 1640 medium (Sigma-Aldrich) supplemented with 10% fetal calf serum; C4-2, PC-3, and DU-145 were cultured in T-medium with 10% fetal calf serum (HyClone Laboratories, Inc., Logan, UT, USA). 30 All cells were cultured at 37°C in a humidified 5% CO 2 atmosphere. Upon reaching 90% confluency, cells were collected either by detachment in 0.5% trypsin containing 0.02% ethylenediaminetetraacetic acid or detached in cold phosphate-buffered saline (PBS) using cell scrapers. No ethical approval was required in the use of these cells for this study.
real-time rT-Pcr
In order to determine the extent of PSMA expression in human tissues and cultured prostate cell lines, we performed PCR assays to measure the amount of PSMA messenger RNA produced. Total RNA was isolated from cells using the RNeasy Kit (Qiagen, Valencia, CA, USA). Contaminating DNA was removed by DNase I treatment (Clontech, Palo Alto, CA, USA). cDNA was synthesized using avian myeloblastosis virus reverse transcriptase (Promega Corporation, Fitchburg, WI, USA) and random hexamer primers (Amersham Biosciences Corporation, Piscataway, NJ, USA) in the presence of RNase inhibitor (Promega Corporation). Realtime RT-PCR was performed in a 7000 Sequence Detection System thermocycler (Thermo Fisher Scientific) using genespecific primer pairs and fluorescent reporter probes (Integrated DNA Technologies, Coralville, IA, USA). To avoid amplification from genomic DNA, intron-spanning primers were used (designed with Primer Express software; Thermo Fisher Scientific). The primers and probe for PSMA were: 5-TGAGAGACTCCAGGACTTTGACAA-3 (forward), 5-GGATCAATAAATGCTCTTTCCAGAA-3 (reverse), and 5-AGCAACCCAATAGTATTAAGAATGATGAAT-GATCAACTCA-3 (probe). For glyceraldehyde-3-phosphate dehydrogenase, commercially available reagents (Thermo Fisher Scientific) were used. Three hundred and fifty nanograms of cDNA were used in a total volume of 25 µL of PCR MasterMix containing 900 nM of the primers and 300 nM of the probe. The cycling conditions were 95°C 10 minutes, 45× (95°C 15 seconds, 60°C 1 minute). No-template and non-reverse transcribed RNA controls were included. The data were analyzed using the Sequence Detection System software (Thermo Fisher Scientific). The expression 
Flow cytometry
Since there is often an imperfect correlation between messenger RNA amounts in cells and the amounts of the translated proteins, we also performed flow cytometry to further investigate the levels of cell surface expression of PSMA. All cells were harvested by trypsinization, centrifuged and resuspended in PBS containing 0.1% azide and 1% bovine serum albumin. Cells were analyzed for cell surface expression of PSMA using either biotinylated or unconjugated MAb 3C6. Fluorescent labeling was achieved with either a fluorescein conjugate of streptavidin or with a phycoerythrin conjugate of rat anti-mouse antibody (BD Biosciences, San Jose, CA, USA). The data were acquired using a Becton Dickinson FACscan flow cytometer (Brea, CA, USA) equipped with a 488 nm argon laser and CellQuest software (CellQuest, San Jose, CA, USA).
Antibody conjugation and cell labeling
Sulfo-NHS-LC-Biotin groups were attached to primary amines of MAb 3C6 using the EZ-Link™ Sulfo-NHS-LCBiotin kit according to the manufacturer's protocol. Conjugated MAb 3C6 was separated from low molecular weight compounds using a Millipore Ultrafree ® -MC Centrifugal Filter Unit (EMD Millipore, Billerica, MA, USA) at a force of 3,000× g in a fixed angle microfuge rotor. Antibody concentration was determined using the Pierce Protein Assay Reagent Kit, and the ratio of biotin/antibody was determined with a Pierce HABA (4′-hydroxyazobenzene-2-carboxylic acid) colorimetric assay, both according to the manufacturer's protocol. Later experiments utilized J591, which was biotinylated using the same method as 3C6 and attached to streptavidin-conjugated SPIONs by incubation for 30 minutes. The free antibody was removed by washing the beads with the aid of a magnetic bead separation device (Miltenyi Biotec). The µMACS ® solution contained 0.05% sodium azide, but no detergent, and was not washed. LNCaP and DU-145 cell suspensions were incubated with biotinylated PSMA for 30 minutes at 4°C, followed by washing with PBS. Labeled cells were incubated with the streptavidin superparamagnetic beads (10 µL bead solution/10 7 cells) for 30 minutes at 4°C with gentle agitation. Cells were separated from unbound beads by repeated centrifugation at 300× g. LNCaP and DU-145 cells were each resuspended in ∼100 µL low melting point 1% agarose in PBS and layered into plastic tubes as described in the MRI sample preparation section below. 
SPION-binding to prostate tumor cells

MrI sample preparation
Magnetic resonance imaging
MRI was carried out using horizontal bore instruments at 1.0 T (MRT Systems, Tsukuba, Japan), at 1.9 T (Oxford Research, Oxfordshire, UK), and at 4.7 T (Bruker Biospec, Billerica, MA, USA). T 2 -weighted images were acquired using spin echo (SE) imaging sequences with echo times (TE) varying from 5.5 to 145.5 ms. T 1 w images were acquired by varying the repetition times (TR) from 0.3 seconds to 12 seconds (for TE ∼4-7 ms). T 1 values were measured with a series of one-dimensional SE images with TE =10.7 ms, and T 2 decay curves were generated using a series of SE images with different TE values. The relaxivities of the SPIONs were determined separately, and bound to cells, in 1% agarose gels by measuring the relaxation rates (r 1 =1/T 1 , r 2 =1/T 2 ) for various [Fe] values (Figure 1 ).
Image processing
The complex, time-domain MRI datasets were baselinecorrected, Fourier-transformed, and co-added using Mathematica version 10 31 based on the measured standard deviations of the pixel intensities for the cells and agarose.
Results
The relaxivity of µMACS and Dynabeads
The NMR water relaxation rate enhancements (relaxivities) of SPIONs depend on the particle size. For this reason, we selected commercially available superparamagnetic particles of two quite different sizes in order to encompass a large range of particle sizes that might be used in practice. Dynabeads are iron oxide particles with a nominal diameter of 1 µm, while µMACS particles are much smaller, with diameters on the order of 50 nm. The magnetic relaxation of water protons is also a function of the rotational correlation time of the water molecule, so that the relaxivities of a SPION depend on the NMR Larmor frequency. 32 For example, for µMACs SPIONs, we found that r 1 (the longitudinal rate enhancement) decreased linearly from 175 Hz/mM at 0.27 T, to 1.67 Hz/mM at 4.7 T. Therefore, it was necessary to measure the relaxivity of a SPION at the same field strength at which it was to be used. At 1.0 T, we determined the r 1 and r 2 relaxivities of the µMACS to be r 1 =38.3±1.1 Hz/mM, and r 2 =800.4±15.9 Hz/mM (mean ± SD, Figure 1 ) and r 1 =0.080±0.0023 Hz/mM and r 2 =32.02±0.91 Hz/mM for the Dynabeads. We found that these relaxivities at 1.0 T were independent of the aggregation state of the SPIONs; they were the same for free SPIONs and SPIONs bound to prostate tumor cells (Figure 1 ). These measurements were also performed at 0.27 T, 1.9 T, and 4.7 T, and the results are given in the figure captions as needed.
Theoretical dependence of contrast on [Fe]
The MRI data were taken at 1.0 T with recycle times ranging from 500 to 5,000 ms, and with echo times from 4 to 145 ms. A typical theoretical calculation of the T 1 w and T 2 w image contrast, and contrast difference, using the measured relaxivities of the µMACS SPIONs at 1.0 T and acquisition parameters within this range shows (Figure 2A) Figure 2B; [Fe] =0.0005051+0.03961 ∆C +0.009258 (∆C) 2 +0.008857 (∆C) 3 . While this inversion is straightforward to perform in Mathematica ® , it needs to be computed for each set of tissue, SPION, and acquisition parameters. It also serves as an essential guide for planning experiments to achieve the optimal sensitivity of contrast to [Fe] . The units of [Fe] naturally arise as mM due to the fact that the longitudinal and transverse relaxivities of the SPIONs are given in Hz/mM; these units set a natural scale to the problem.
Comparison of the theoretical dependence of [Fe] with iron assay
To validate this method we compared the theoretical predictions with independent measurements of the [Fe] in MRI samples prepared from 1% agarose gels containing known concentrations of SPIONs. After the MRI measurements, the gels were removed from the tubes and the [Fe] was measured using the Prussian blue iron assay (see "Materials and methods"). Even though the relationship between pixel contrast difference and [Fe] was clearly non-linear ( Figure 2B ). It was still monotonic and single-valued and could therefore be used to convert ∆C into [Fe] . Thus, the data show ( Figure 2C ) that we can accurately measure [Fe] with this method; the slope of the fitted line is 1.024±0.041, which is not statistically, significantly different from 1.0, with an intercept of 0.5 µM Fe.
Determination of the LOD of iron using [Fe]MrI
A Dynabead stock solution was diluted 1:6,250, 1:1,250, and 1:250 into 1% agarose and placed into 10 mm plastic tubes as bands surrounded by agarose. A T 1 w MR image was taken ( Figure 3A) at TR =1 second, TE =5 ms, nex =6, and a T 2 -weighted image ( Figure 3B ) was taken at TR =1 second, TE =115 ms. The resulting [Fe]MR image ( Figure 3C ) showed detectable bands for [Fe] =9.7 and 48 µM, with a barely detectable band at [Fe] =1.97 µM. These bands were more easily seen and quantitated by means of a Mathematicagenerated three-dimensional surface plot ( Figure 3D 
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sillerud a signal to noise ratio of only 1.6, which was less than 2σ different from the noise, and therefore not a candidate detection. Thus, we found a detection limit of ∼2-2.5 µM Fe, for a signal to noise ratio of ∼45:1 for the input T 1 w and T 2 w images. It appears to be an easy task to improve this LOD by acquiring higher signal to noise ratio images.
Specific binding of anti-PSMA-conjugated sPIONs to PsMa-positive prostate tumor cells
The [Fe]MRI measurement of [Fe] in SPION preparations in vitro was interesting in its own right, but the application of this method to biological samples was our primary goal. Our long history of applications of NMR to prostate cancer diagnosis 2, 25, 26, [33] [34] [35] [36] [37] suggested that we turn to this area for a candidate cell-surface epitope to discriminate between cancer cells and normal, non-malignant cells. Research on prostate cancer-specific cell markers 25, [27] [28] [29] led to the identification of PSMA, the folate receptor, as a cell-surface protein that is highly-overexpressed on prostate tumors. PSMA is a cell-surface protein expressed in the prostate at levels a 1,000-fold greater than that found in other tissues, such as kidney. 38 The expression of PSMA increases in prostate cancer and its expression is correlated with tumor grade, pathological stage, aneuploidy, and biochemical recurrence. 28 A humanized antibody to PSMA, J591, has been successfully used to image sites of metastasis. [38] [39] [40] [41] [42] [43] Once a tumor-specific epitope had been identified, we sought cell lines that differed in its expression. The expression of PSMA at the level of mRNA was measured using reverse transcriptase polymerase chain reaction (RT-PCR), and the cell-surface protein expression confirmed using flow The anti-PSMA antibody, 3C6, was conjugated to the surface of the various SPIONs. Binding assays (Figure 4 ) in vitro showed that, on average, LNCaP cells (n=100) bound 80±16 of the 1 µm anti-PSMA-conjugated Dynabeads per cell, roughly consistent with our earlier order of magnitude estimates (vide supra). The control, PSMA-negative DU145 cells did not bind significant amounts of the anti-PSMA-conjugated SPIONs.
MrI contrast as a function of [Fe] for LNCaP cells with anti-PSMA-conjugated sPIONs
The theoretical relationship between MRI contrast and [Fe] (Figure 2A ) predicted that for low [Fe] the T 1 w image contrast would be positive, while the T 2 w contrast would be negative for cells that bound SPIONs. While a test of this relationship (Figure 3) showed that these predictions were qualitatively correct, it was of further interest to numerically compare these predicted relationships with measurements. We found ( [Fe]MrI determination of [Fe] for anti-PSMA-conjugated µMACS SPIONs bound to PsMa-positive prostate tumor cells There are two, equally-valid methods for the specific SPION labeling of PSMA-positive tumor cells. The first closely follows the logic for immunohistochemistry in which the PSMA-positive LNCaP cells were incubated with biotinylated anti-PSMA antibody, washed to remove free antibody, incubated with streptavidin-conjugated µMACS SPIONs, washed to remove unbound SPIONs, and mixed with 0.1 mL of 1% agarose. The specificity for PSMA is preserved because the biotinylated antibody would bind only very weakly to PSMA-negative DU145 cells and produce only a small fraction of biotin-binding sites for the streptavidinconjugated µMACS SPIONs. The second method involves binding the streptavidin-conjugated µMACS SPIONs to biotinylated PSMA, washing the SPIONs and incubating them with the cells and/or tissues. We initially used the first method in this work since one had direct access to the cell surface; we later switched to the second method because it was more appropriate for performing subsequent animal studies. The details for both techniques are given in the "Materials and methods" section. Since the results did not depend on the order of the labeling, we refer to the SPIONs as PSMA-conjugated for simplicity.
Aliquots containing 2×10 6 , 1×10 Figure 6D ). Again, we find that the limit of Fe detection was ∼2 µM. Other studies have found similar amounts of Fe in cells treated with SPIONs; for example, We have shown that µMACS bind to anti-PSMA-conjugated LNCaP Cells at 4°C, but are not taken up into the cytoplasm until the cells are warmed to 37°C, at which temperature the SPIONs are rapidly internalized with a time constant of 5-7 minutes. 26 It was of interest, therefore, to bind SPIONs to the cell surface at 4°C and then to allow internalization by raising the temperature. We prepared a cell phantom in agarose, as before, and used [Fe] MRI to measure the [Fe] . The results (Figure 7) showed that we could still observe a strong [Fe]MRI signal from the internalized SPIONs, and that this signal scaled linearly with the number of cells, as shown in Figure 6 . We found that these cells took up (26.2±1.2)×10
[Fe]MRI of anti-PSMA-conjugated SPIONs discriminates PsMa-positive from PsManegative prostate tumor cells
To use anti-PSMA-conjugated SPIONs for the specific detection of prostate tumors, one must first show that these SPIONs can distinguish cells based on their expression of PSMA. showed that LNCaP cells were PSMA-Positive, while DU145 cells expressed 100-fold less PSMA and were therefore essentially PSMA-negative. We incubated biotinylated-anti-PSMA with LNCaP and DU145 cells, washed the cells to remove unbound 3C6, and then incubated equal numbers of each of these cells with streptavidin-conjugated SPIONs, washed away the unbound particles, and prepared agarose gels in plastic tubes. When we applied [Fe] MRI to these samples, we found (Figure 8 ) that the LNCaP cells bound 8.7-fold more of these SPIONs than the DU145 cells, indicating excellent specificity for the detection of cell-surface PSMA.
Discussion
We have developed, presented and applied a general, quantitative, multiparametric MRI theory for the measurement of nanoscale magnetic objects introduced into biological systems. This new ability to directly, and simply, measure the amount of a nanoparticle, or other magnetic material using standard MRI, will enhance a large class of nanotechnology studies. The present LOD for [Fe]MRI was found to be ∼2 µM, but that could evidently be lowered through judicious choices of the relaxivity of the objects, which in this case were SPIONs, and by calculating and optimizing the contrast and signal to noise ratio based on varying the MRI acquisition parameters. We found that expected concentrations of iron could be detected from SPIONs and from SPIONs bound to and internalized by cells. This allowed us to show that [Fe]MRI could discriminate among prostate tumor cell types based on the expression, or lack thereof, of cell surface tumor markers; in this particular case of PSMA. One can envision a large range of other applications of [Fe]MRI. Previous attempts [13] [14] [15] [16] [17] [18] [19] at iron-specific imaging have relied on the alteration in T 2 or T 2 * by iron. These methods do not produce images, as we do, where the intensity is solely, and unambiguously, dependent on [Fe] as we propose here. They rely on the assumption that the [Fe] is the sole determinant of either T 2 or T 2 *, and ignore the many other contributions to transverse relaxation. Other methods, such as QSM, [47] [48] [49] require measurement of the absolute tissue susceptibility and suffer from the large background variations in the phase of the MR image due to susceptibility variations independent of [Fe] or from susceptibility jumps at the air-tissue boundaries of the body. Also, the expertise and software to accomplish QSM are not widely available. We have developed a method that is easy to apply, using only T 1 w and T 2 w images available on any MRI system. This ease of implementation should result in the widespread application of [Fe] MRI to a large class of biological, and physical-chemical problems. Note that [Fe] MRI is primarily a method for the quantitative imaging of added Fe arising, for example, from the injection of magnetic agents, and is not a method for the determination of total tissue iron, because the background MRI signals are removed from the analysis to produce the basic contrast images.
The sensitivity of [Fe]MRI compares favorably with other MRI methods. Our current LOD was 2 µM Fe. Dahnke and Schaeffter 13 report an LOD for SPIONs, using a relatively complicated scheme for ∆Bo corrections to T2* mapping, of 43 µM in the brain and 144 µM in the liver. At the extreme upper range of potential physiological concentrations that might be used for tumor hyperthermia, Garwood's laboratory used SWIFT to map [Fe] up to ∼50 mM. 50 Girard et al 19 using QSM report slopes of 1.760 ppm/mM Fe in vitro, so that our LOD corresponds to a susceptibility shift of 0.45 ppm at 3 T, which is easily measurable. He et al 11 measured [Fe] in the brain using QSM but the determined slope of the relationship between ∆Χ and [Fe] is so small in vivo (∼16 ppm/mol Fe) that [Fe] smaller than ∼1 mM results in ∆Χ values too small to measure. Our LOD is 500 times lower than this. Gunn et al, 12 used proton NMR spectroscopy in vitro to measure [Fe] with a LOD of ∼0.2 nM, but this in vitro method is destructive and cannot be used in vivo. The current US Food Given the ability to produce quantitative maps of the distribution of nanoscale magnetic objects (superparamagnetic nanoparticles, soluble paramagnetic agents like gadolinium, manganese, cobalt, etc) one can anticipate extensions of the work presented here. Clearly, it is possible to measure, monitor, and follow the time course of injected magnetic materials in the body. For example, in the work to be reported separately, we have used [Fe] MRI to image the [Fe] as a function of time for SPIONs injected into prostate tumor xenografts in mice, and to follow the time course of anti-PSMA-conjugated SPIONs as they infiltrate and bind to prostate tumor xenografts after intravenous injection. We have previously published MRI studies in which chemotherapeutic drugs were incorporated into superparamagnetic FePt nanomicelles for the simultaneous imaging 33 and the treatment of prostate tumor xenografts in mice. 2 In the present situation, by knowing the relationship between the amount of drug, and the amount of iron, in the nanoparticles, it becomes feasible to envision the [Fe]MRI signal as a surrogate for the [drug] in the tissue of interest to measure drug dosage to the tumor, non-invasively. One area in which this information would be of critical importance is for the chemotherapy of brain tumors where it is not accurately known if the drug actually reaches the tumor in therapeutic concentrations. 51 Such information is currently only available with positron emission tomography imaging of expensive, short-lived, radioactively-labeled molecules. Our [Fe] MRI technology will open this field to a large variety of additional studies that were previously thought to be too expensive, or impractical.
Another of the many potential applications of [Fe]MRI would be to measure the infiltration of tissues by macrophages. For example, diabetic osteomyelitis is accompanied by a massive influx of these cells as the body attempts to clear the infection. Macrophages take up iron-containing nanoparticles, such as ferumoxytol, and serve as carriers of MRI contrast into the tissue. By means of [Fe]MRI, one could potentially infer the macrophage density, and hence the severity of infection, through [Fe] MRI measurements of the [Fe] in the affected tissues. 52, 53 We are currently pursuing a human clinical trial of these concepts.
